Yahoo Web Search

Search results

1. • 

     Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Singapore Finance· 2 months ago

     Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript May 9, 2024 Oncolytics...

2. • Q1 2024 Veracyte Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Singapore Finance· 2 months ago

     Participants Shayla Gorman; Senior Director, Investor Relations; Veracyte Inc Marc Stapley; Chief Executive Officer, Director; Veracyte Inc Rebecca Chambers; Chief Financial Officer; Veracyte ...

3. • Q4 2023 Cue Biopharma Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Singapore Finance· 3 months ago

     Participants Daniel Passeri; Chief Executive Officer, Director; Cue Biopharma Inc Anish Suri; President, Chief Scientific Officer; Cue Biopharma Inc Matteo Levisetti; Chief Medical Officer; ...

4. • 

     Gritstone (GRTS) Plummets 58% in a Week: Here's Why

     Zacks via Yahoo Singapore Finance· 3 months ago

     Gritstone (GRTS) plunges after a mid-stage study evaluating its personalized cancer vaccine in certain patients with colorectal cancer failed to achieve...

5. • 

     Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Singapore Finance· 3 months ago

     Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript March 21, 2024 Fennec...

6. • 

     Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Singapore Finance· 3 months ago

     Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript March 19, 2024 Precigen, Inc. misses...

7. • Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress

     GuruFocus.com via Yahoo Singapore Finance· 3 months ago

     Net Loss: Q4 net loss widened to $22.8 million from $12.9 million in the same period last year. Research and Development Expenses: R&D expenses increased to $20.7 million in Q4, up from $10.4 ...

8. • Q4 2023 CytomX Therapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Singapore Finance· 4 months ago

     Participants Chris Ogden; SVP, Finance and Accounting; CytomX Therapeutics Inc Sean McCarthy; CEO & Chairman; CytomX Therapeutics Inc Joe Catanzaro; Analyst; Piper Sandler & Co Anupam Rama; ...

9. • Q4 2023 Zymeworks Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Singapore Finance· 4 months ago

     Participants Shrinal Inamdar; Director, Investor Relations; Zymeworks BC Inc Chris Astle; Chief Financial Officer & Senior Vice President; Zymeworks BC Inc Paul Moore; Chief Scientific Officer ...

10. • Q4 2023 Cardiff Oncology Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Singapore Finance· 4 months ago

      Participants Laurence Watts; IR; Gilmartin Group LLC Mark Erlander; Chief Executive Officer; Cardiff Oncology Inc James Levine; Chief Financial Officer; Cardiff Oncology Inc Fairooz Kabbinavar ...